In a significant move towards enhancing drinking water safety, the U.S. Environmental Protection Agency (EPA) has proposed for the first time to add microplastics and pharmaceuticals to its list of contaminants. This initiative, announced on 2 April 2026, aims to address growing public concern regarding the potential health risks posed by these substances in drinking water supplies. The proposal is seen as a pivotal step in the ongoing effort to combat plastic pollution and its associated health implications.
New Contaminant Candidate List
The EPA’s Contaminant Candidate List (CCL) identifies substances in drinking water that are not currently regulated under the Safe Drinking Water Act. The agency has published a draft of its sixth iteration of the CCL, which opens a public comment period lasting 60 days, with expectations to finalise the list by mid-November. EPA Administrator Lee Zeldin highlighted the importance of this initiative, stating, “I can’t think of an issue that hits closer to home for American families than the safety of their drinking water.”
The inclusion of microplastics and pharmaceuticals is a response to rising public anxiety about these contaminants. Studies have indicated the presence of microplastics not only in drinking water but also within human organs, raising questions about their health consequences. The concern extends to pharmaceuticals that enter water systems through human excretion, which conventional wastewater treatment methods often fail to eliminate.
The Road Ahead
While this announcement has garnered praise from environmental advocates, some experts caution that it merely marks the beginning of a lengthy regulatory process. Erik Olson, a senior attorney with the Natural Resources Defense Council, remarked, “It’s the beginning of a very long process that routinely ends in nothing.” The EPA has historically struggled to move pollutants from the CCL to regulatory status, as evidenced by its recent decision not to establish regulations for any of the nine contaminants it reviewed last month.
Judith Enck, a former regional administrator with the EPA and current head of Beyond Plastics, believes that this is a crucial first step. “Including it in the list would be the first step toward eventually regulating microplastics in public water supplies,” she stated, emphasising the necessity of ongoing efforts to tackle plastic pollution.
Activism and Political Ties
This proposal aligns with the objectives of health secretary Robert F. Kennedy Jr.’s Maha movement, which has been advocating for stricter regulations concerning environmental contaminants. The movement has expressed frustration over perceived inaction on several priorities, including pesticide regulation, despite forging a fragile alliance with the EPA. Kennedy has been vocal about the need for comprehensive measures to address plastic pollution, announcing a $144 million initiative, dubbed Systematic Targeting of Microplastics (Stomp), to better understand and mitigate microplastics in human bodies.
Kennedy’s remarks at the EPA underscore the urgency of the issue: “We can’t treat what we cannot measure. We cannot regulate what we don’t understand.” His campaign for the 2024 presidential election has made tackling plastic pollution a central theme, reflecting the growing public demand for environmental accountability.
Industry Response and Future Directions
The American Chemistry Council, an industry group, has expressed support for monitoring microplastics in drinking water, contingent upon the establishment of consistent national standards. Meanwhile, advocates from Food & Water Watch argue that the mere listing of microplastics is inadequate without comprehensive monitoring and regulatory measures in place.
As the EPA prepares to address the concerns raised by Kennedy’s movement and other advocacy groups, it has signalled an upcoming agenda focused on critical environmental issues, including “forever chemicals” and lead in drinking water systems. However, the effectiveness of these initiatives will largely depend on the agency’s willingness to impose meaningful regulations.
The Safe Drinking Water Act requires the EPA to publish the CCL every five years and mandates the agency to consider regulating at least five contaminants from the list. Historically, however, regulatory action has been minimal, as the agency has often determined that no action is necessary for many substances reviewed.
Why it Matters
The EPA’s proposal to include microplastics and pharmaceuticals on its list of contaminants signals a potential turning point in the United States’ approach to drinking water safety and environmental health. As public awareness of plastic pollution escalates, the agency’s actions will be closely scrutinised. Effective regulation could not only safeguard public health but also set a precedent for addressing the broader environmental challenges posed by plastic production and waste. The evolution of this policy will be critical, not only for the health of Americans but also for the future of sustainable water management and environmental integrity globally.
